Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata often have low vitamin D levels, which may worsen their hair loss.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

In 2017, a new method was created to efficiently produce a topical antiandrogen, a compound used to treat excess sebum and acne, with a high yield and purity.

Some parents have a mild form of congenital adrenal hyperplasia without symptoms, and they usually don't need treatment.

Two new methods accurately measure Aminexil, Pyridoxine, and Niacinamide in hair products.

Korean women with female pattern hair loss have higher levels of ferritin, testosterone, and vitamin D than average.

Vitiligo patients often have other health issues, especially thyroid disorders.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

Topical calcitriol-analogs can reduce hair loss caused by chemotherapy.

People with alopecia areata had lower vitamin D levels, but these levels did not relate to how severe their condition was.

No single treatment is clearly effective for central serous chorioretinopathy.

RCS-01 therapy is safe and may improve skin structure by affecting gene expression.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

Adding soybean oil to Nonomuraea dietziae increases production of a beneficial compound by improving metabolism and enzyme systems.

Claudin-1 is important for the barrier function and growth of hair.

Procyanidin compounds from apples and barley promote hair growth and prevent hair cell death.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

Two compounds from Asiasarum heterotropoides roots show potential as lung cancer treatments without harming normal cells.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

ERULUS controls root hair growth by regulating cell wall composition and pectin activity.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

A cream with a specific hormone blocker increases hair growth in mice.